Brainsway Ltd.
BWAY | TA
Overview
Corporate Details
- ISIN(s):
- IL0011007189
- LEI:
- Country:
- Israel
- Address:
- 16 Hartum St, 9777516 Har Hotzvim, Jerusalem
- Website:
- https://www.brainsway.com/
- Sector:
- Health Care
- Industry:
- Health Care Technology
Description
Brainsway develops advanced medical technologies for treating brain disorders.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-11 16:30 |
Foreign Filer Report
BrainsWay Reports Positive Results from Multicenter Randomized Study of Acceler…
|
English | 357.5 KB | |
| 2025-06-11 16:30 |
Foreign Filer Report
BrainsWay Reports Positive Results from Multicenter Randomized Study of Acceler…
|
English | 36.5 KB | |
| 2025-06-04 16:30 |
Foreign Filer Report
BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC
|
English | 303.4 KB | |
| 2025-06-04 16:30 |
Foreign Filer Report
BrainsWay Announces $5 Million Minority-Stake Investment in Stella MSO, LLC
|
English | 36.4 KB | |
| 2025-05-13 16:30 |
Foreign Filer Report
BrainsWay Reports First Quarter 2025 Financial Results and Operational Highligh…
|
English | 218.2 KB | |
| 2025-05-13 16:30 |
Earnings Release
BrainsWay Reports First Quarter 2025 Financial Results and Operational Highligh…
|
English | 36.4 KB | |
| 2025-04-23 01:05 |
Registration Form
FORM F-3 - REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
|
English | 1.2 MB | |
| 2025-04-23 01:05 |
Foreign Filer Report
FORM F-3 - REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
|
English | 36.3 KB | |
| 2025-04-22 15:00 |
Annual Report
Form 20-F for the Year Ended December 31, 2024
|
English | 5.9 MB | |
| 2025-04-22 15:00 |
Foreign Filer Report
Form 20-F for the Year Ended December 31, 2024
|
English | 36.5 KB | |
| 2025-03-11 14:30 |
Earnings Release
FORM 6-K-Fourth Quarter and Full Year 2024 Financial Results and Operational Hi…
|
English | 237.4 KB | |
| 2025-03-11 14:30 |
Earnings Release
FORM 6-K-Fourth Quarter and Full Year 2024 Financial Results and Operational Hi…
|
English | 36.4 KB | |
| 2025-01-29 00:00 |
Major Shareholding Notification
SCHEDULE 13G-Avner Hagai
|
English | 200.5 KB | |
| 2025-01-29 00:00 |
Foreign Filer Report
SCHEDULE 13G-Avner Hagai
|
English | 36.2 KB | |
| 2024-12-12 15:59 |
Registration Form
Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of
Al…
|
English | 49.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Diagonal Bio AB | Sweden | DIABIO | |
| EDX Medical Group Plc | United Kingdom | N/A | ||
|
Elekta | Sweden | EKTA | |
|
Elos Medtech | Sweden | ELOS | |
|
Episurf | Sweden | EPIS | |
|
FluoGuide A/S | Denmark | FLUO | |
|
GELION PLC | United Kingdom | GELN | |
|
Genetic Analysis AS | Norway | GEAN | |
|
Genomed Spolka Akcyjna | Poland | GEN | |
|
Genomtec S.A. | Poland | GMT |